Canadian cancer researchers are part of global efforts to test targeted alpha therapy, a new form of treatment that some ...

Gamma delta (γδ) T cells hold significant potential for unmet medical needs. Yet they are more challenging to source than ...

Gamma delta (γδ) T cells hold significant potential for unmet medical needs. Yet they are more challenging to source than other T cells, representing as little as 1% to 5% of the total CD3+ T ...

Gadeta has developed a technology to engineer alpha beta T cells with gamma delta T-cell receptors, with an enhanced anti-cancer activity, that it hopes could overcome this hurdle. The cells could ...